Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probiotics: which and when?

E Scarpellini1, A Cazzato, C Lauritano

  • 1Internal Medicine Institute, Catholic University of Sacred Heart, Gemelli Hospital, Rome, Italy. scarpidio@gmail.com

Digestive Diseases (Basel, Switzerland)
|April 24, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spondylodiscitis: is really all well defined?

European review for medical and pharmacological sciences·2019
Same author

Isthmic spondylolisthesis and interspinous process device. Hype, hope, or contraindication?

European review for medical and pharmacological sciences·2019
Same author

Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines.

Journal of biological regulators and homeostatic agents·2019
Same author

Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation?

Journal of translational medicine·2019
Same author

Medicine in the time of Carracci: the cases of Domenico Lanzoni and Giuseppe Rosaccio.

European review for medical and pharmacological sciences·2019
Same author

Acute HEV hepatitis: clinical and laboratory diagnosis.

European review for medical and pharmacological sciences·2019
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Probiotics, beneficial gut bacteria, impact host health but their mechanisms and effectiveness remain largely unproven. This review guides understanding of the complex gut microbial universe and probiotic applications.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Immunology

Background:

  • The human gut harbors a complex microbial ecosystem (intestinal flora) crucial for host homeostasis.
  • Disruptions to the gut barrier can lead to infections and sepsis originating from gut microorganisms.
  • Probiotics, live microorganisms intended to confer health benefits, have a growing global market.

Purpose of the Study:

  • To provide an evidence-based review of the current understanding of probiotics.
  • To clarify the mechanisms, effective strains, expected outcomes, and optimal dosages of probiotics.
  • To guide readers through the complexities of the gut microbiome and its influence on health.

Main Methods:

  • Comprehensive literature review of scientific publications on probiotics and gut microbiota.

Related Experiment Videos

  • Analysis of existing evidence regarding probiotic efficacy and mechanisms of action.
  • Synthesis of data to address key questions about probiotic use.

    • Main Results:

    • While probiotics are widely marketed, robust scientific evidence for their efficacy and mechanisms is often lacking.
    • Specific probiotic strains and dosages for particular health conditions require further rigorous investigation.
    • The interaction between probiotics and the host's gut microbiota is complex and not fully elucidated.

    Conclusions:

    • More high-quality research is needed to substantiate probiotic health claims.
    • Understanding the gut microbiome is essential for developing targeted and effective probiotic therapies.
    • Consumers should approach probiotic marketing with critical evaluation based on scientific evidence.